Jeena Sikho Lifecare Reports Q2FY27 Results and Outlines Bed Expansion Strategy
Jeena Sikho Lifecare Ltd · Investor Presentation · 16 Nov 2026, 2:44 am
Jeena Sikho Lifecare Reports Q2FY27 Results and Outlines Bed Expansion Strategy Jeena Sikho Lifecare reported Q2FY27 revenue growth of 24% YoY to ₹235.13 crore, while EBITDA declined 22% YoY to ₹72.02 crore with margins contracting to 31% from 48% in Q2FY26. Profit after tax fell 38% YoY to ₹36.34 crore, impacted by brand-building outlays, manpower additions, and higher ECL provisions. H1FY27 revenue rose 26% YoY to ₹459.53 crore with a 36% EBITDA margin. Operating 2,424 beds across 122 facilities, the debt-free company targets scaling to 5,000 beds within 2–5 years via internal accruals.
Original exchange filing (PDF)
More announcements from Jeena Sikho Lifecare Ltd
- Commencement of operations at the new Client Support Centre Facility at Noida, Uttar Pradesh. · 18 Nov 2026
- Submission of audio recording of Earnings Conference Call - Q2 FY 2026-27 · 16 Nov 2026
- Jeena Sikho Lifecare Limited has submitted to the Exchange, Outcome of the Meeting of the Board of Directors of Jeena Sikho Lifecare Limited held on November 14, 2026 for the declaration of Unaudited financial results (Standalone and Consolidated) for the period ended September 30, 2026. · 15 Nov 2026
- Declaration of Unaudited Financial Results (Standalone & Consolidated) for Quarter and Half year ended 30.09.2026 · 15 Nov 2026
- Unaudited Financial Results (Standalone & Consolidated) for quarter and half year ended 30.09.2026 · 15 Nov 2026
- Intimation of Schedule of Analyst / Investor Meet/ Conference under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 · 13 Nov 2026
- Incorporation of Subsidiary Company · 11 Nov 2026
- Launch of New Products · 11 Nov 2026
